246 related articles for article (PubMed ID: 11804262)
1. Ketoconazole and Flutamide in the treatment of disseminated intravascular clotting from prostate cancer: a case report and review.
Chakrapee-Sirisuk S; Amornpichetkul K; Visudhiphan S; Sangruchi T; Srimuninnimit V; Sinlarat P
J Med Assoc Thai; 2001 Oct; 84(10):1495-501. PubMed ID: 11804262
[TBL] [Abstract][Full Text] [Related]
2. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
3. Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer.
Duran I; Tannock IF
J Gen Intern Med; 2006 Nov; 21(11):C6-8. PubMed ID: 17026724
[TBL] [Abstract][Full Text] [Related]
4. The use of ketoconazole in the emergency management of disseminated intravascular coagulation due to metastatic prostatic cancer.
Lowe FC; Somers WJ
J Urol; 1987 May; 137(5):1000-2. PubMed ID: 3573156
[TBL] [Abstract][Full Text] [Related]
5. [Prostate cancer and acute disseminated intravascular coagulation. Therapeutic management based on three cases].
Avances C; Oumaya C; Granger V; Dubon O; Gris JC; Culine S; Costa P
Prog Urol; 2003 Apr; 13(2):308-12. PubMed ID: 12765072
[TBL] [Abstract][Full Text] [Related]
6. [Prostate cancer and disseminated intravascular coagulation: review of the literature].
Chargari C; Vedrine L; Bauduceau O; Le Moulec S; Fayolle M; Ceccaldi B; Houlgatte A
Prog Urol; 2008 Jan; 18(1):9-13. PubMed ID: 18342149
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy in prostate cancer.
de la Fouchardière C; Flechon A; Droz JP
Neth J Med; 2003 Nov; 61(11):347-54. PubMed ID: 14768717
[TBL] [Abstract][Full Text] [Related]
8. Resolution of thrombocytopenia secondary to disseminated intravascular coagulation with docetaxel chemotherapy in prostate cancer.
Talebi TN; Manoharan M; Singal R
Am J Ther; 2012 Jan; 19(1):e59-61. PubMed ID: 20535002
[TBL] [Abstract][Full Text] [Related]
9. Challenging problems in advanced malignancy: Case 2. Disseminated intravascular coagulation in metastatic hormone-refractory prostate cancer.
Kampel LJ
J Clin Oncol; 2003 Aug; 21(16):3170-1. PubMed ID: 12915609
[No Abstract] [Full Text] [Related]
10. [Clinical study on prostate cancer initially presenting with disseminated intravascular coagulation syndrome].
Ohtake N; Kurita S; Fukabori Y; Imai K; Yamanaka H; Nakata S; Sato J; Kurihara J; Mashimo M; Sekihara T; Saruki K; Kawashima K; Takahashi H; Tsuchiya K; Okabe K; Jimbo S; Kurita M
Hinyokika Kiyo; 1998 Jun; 44(6):387-90. PubMed ID: 9719936
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy, following medical therapy, for carcinoma of the prostate.
Bern MM
Hematology; 2005 Feb; 10(1):65-8. PubMed ID: 16019449
[TBL] [Abstract][Full Text] [Related]
13. Disseminated intravascular coagulation in cancer patients.
Levi M
Best Pract Res Clin Haematol; 2009 Mar; 22(1):129-36. PubMed ID: 19285279
[TBL] [Abstract][Full Text] [Related]
14. [Favorable outcome of neoplastic disseminated intravascular coagulation treated with ketoconazole and estrogen derivative].
Fleyfel M; Leroy B; Plouvier F; Balin C; Marecaux O; Scherpereel P
Ann Fr Anesth Reanim; 1991; 10(4):406-8. PubMed ID: 1928864
[TBL] [Abstract][Full Text] [Related]
15. Emergency treatment with ketoconazole in disseminated intravascular coagulation due to metastatic prostatic carcinoma.
Bhadoria DP; Mukhopadhyay DK; Mehta S; Mittal D; Rao YV; Malhotra KK
J Assoc Physicians India; 1989 Dec; 37(12):792-3. PubMed ID: 2636587
[TBL] [Abstract][Full Text] [Related]
16. Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature.
Hyman DM; Soff GA; Kampel LJ
Oncology; 2011; 81(2):119-25. PubMed ID: 21986538
[TBL] [Abstract][Full Text] [Related]
17. The pathogenesis and management of disseminated intravascular coagulation.
Saba HI; Morelli GA
Clin Adv Hematol Oncol; 2006 Dec; 4(12):919-26. PubMed ID: 17235277
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
Patel H; Rhee E; Zimmern PE
J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
[TBL] [Abstract][Full Text] [Related]
19. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
20. [First line therapy in the treatment of metastatic prostate cancer].
Sakai H; Kanetake H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]